Molecular Formula | C29H31F2N3O |
Molar Mass | 475.57 |
Density | 1.1634 (estimate) |
Melting Point | 187.5-190° |
Boling Point | 668.9±55.0 °C(Predicted) |
Solubility | DMSO: soluble |
Appearance | amorphous solid |
Color | white to yellow |
pKa | 15.05±0.20(Predicted) |
Storage Condition | room temp |
In vitro study | Fluspirilene, at concentrations which non-competitively modify dihydropyridine binding, selectively antagonizes the effects of calcium-channel activators. Fluspirilene decreases the viability and suppresses sphere-forming of glioma stem cell lines in a dose-dependent manner. Fluspirilene demonstrates the inhibition of proliferation of T98, U87 and all GSC lines at 1.25, 2.5, and 5 μM, while it inhibits the proliferation of U251 and SNB19 at 2.5 and 5 μM. |
In vivo study | Mice treated with fluspirilene shows a remarkable reduction of the tumor size. Fluspirilene significantly prolongs survival of the TGS04 mouse model. |
UN IDs | 3249 |
WGK Germany | 3 |
RTECS | XX8750000 |
Hazard Class | 6.1(b) |
Packing Group | III |
Toxicity | LD50 i.m. in rats: 146 ±14 mg/kg (Janssen) |